ArticleScientific reports2025
Design, spectroscopic analysis, DFT calculations, adsorption evaluation, molecular docking, comprehensive in silico and in vitro bioactivity studies of thiocarbohydrazide grafted dialdehyde cellulose nanobiosorbent.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Novel delafossite structured visible-light sensitive AgFeOScientific reports · 2026Article
- Novel aminothiazole grafted cellulose composite for efficient removal of Hg(II) from wastewater in single and multicomponent systems.Scientific reports · 2025Article
- Pristine corn kernels as a pH-responsive biosorbent for selective removal of cationic and anionic dyes.BMC chemistry · 2025Article
- Significance of Nano Transition Metal Complexes as Anticancer and Antibacterial Therapeutic Agents.International journal of molecular sciences · 2025Article
- Design, Synthesis,ACS omega · 2025Article
- Synthesis, Characterization and Molecular Modeling of Novel Oxoethyl methacrylate Polymers.ACS omega · 2025Article
- Targeting IDO1 in Huntington's Disease: Network Pharmacology and Preclinical Evidence from Coffea arabica.Neurochemical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heavy metals have attracted considerable attention lately because of their widespread occurrence in aquatic environments and potential biological toxicity to animals and human. The current investigation focused on synthesizing the DAC@TCH nanobiosorbent by coupling dialdehyde cellulose with thiocarbohydrazide ligand. Subsequent characterization of DAC@TCH was carried out utilizing various analytical methods such as elemental analysis, scanning electron microscopy (SEM), transmission electron microscopy (TEM), Fourier transform infrared (FT-IR), and thermogravimetric analysis (TGA and DTA). DFT calculations were utilized to verify the molecular structure, analysis of frontier molecular orbitals (FMOs), molecular electrostatic potential (MEP) and reactivity descriptor for all phases. In vitro experiments were conducted to evaluate the biological properties of the DAC@TCH nanobiosorbent. These findings revealed that the synthesized DAC@TCH nanobiosorbent has been observed to show effective antibacterial IZD value against E. Coli (28 mm) which is superior to the efficacy of standard drug amoxicillin used (5 mm). Furthermore, in silico antibacterial activities (molecular docking) of the DAC@TCH have indicated this to exhibit excellent efficacy with docking score of (-7.4237 kcal/mol) and (-7.1325 kcal/mol) for S. aureus and, E. coli, respectively. Meanwhile the binding energies (best docking scores) in kcal/mol for Amoxicillin are (-5.8090) and (-6.7442) for S. aureus and, E. coli, respectively. Drug-likeness rules like Lipinski's, Veber's and Egan's were considered for a more comprehensive evaluation. The prepared DAC@TCH nanobiosorbent was investigated for its potential to adsorb metal ions (Ag
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.